Keywords: درمان هدفمند; Aptamer; Cancer therapy; Drug delivery systems; Nanoparticles; Nanomedicine; Targeted therapy; Theranostics;
مقالات ISI درمان هدفمند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان هدفمند; Triple negative breast cancer; Asian women; Risk factors; Chemotherapy; New promising biomarkers; Targeted therapy;
Keywords: درمان هدفمند; Clinical next-generation sequencing; Clinical Trials; Gene panels; Precision oncology; Targeted therapy;
Keywords: درمان هدفمند; Gastrointestinal cancer; chemotherapy; targeted therapy; severity; distress; pain; fatigue; sleep disturbance; taste changes; feeling drowsy;
Keywords: درمان هدفمند; Insulin-like Growth Factor-1 (IGF-1); Breast cancer; Targeted therapy; Insulin-like Growth Factor-1 Receptor (IGF-1R); Insulin-like Growth Factor Binding Proteins (IGFBPs); Estrogen Receptor (ER);
Keywords: درمان هدفمند; Ligand-functionalized liposomes; Dual-functionalized liposomes; EPR effect; Tumor heterogeneity; Targeted therapy; Nanomedicine;
Keywords: درمان هدفمند; Triple-negative breast cancer; Targeted therapy; Combination therapy; Biomarkers;
Keywords: درمان هدفمند; Neuroblastoma; Targeted therapy; Investigational drugs; MYCN; ALK; Ras/MAPK; Clinical trial; Immunotherapy;
Keywords: درمان هدفمند; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ADAM; a disintegrin and metalloproteinase enzymes; ALDH; aldehyde dehydrogenase; ABC; ATP - binding cassette; BWS; Beckwith-Wiedemann syndrome; BMP; bone morphogenetic proteins; CSC; cancer s
Keywords: درمان هدفمند; Gallbladder cancer; Biomarkers; Targeted therapy; Molecular profiling;
Keywords: درمان هدفمند; Chronic lymphocytic leukemia; CLL; Older adults; Targeted therapy;
Keywords: درمان هدفمند; Biomarkers; Biospecimens; Clinical research; Delay; Personalized medicine; Targeted therapy;
Keywords: درمان هدفمند; Dose titration; Progressive disease; RCC; Targeted therapy; Tyrosine kinase inhibitor;
Keywords: درمان هدفمند; Salivary gland carcinoma; ACC; Metastatic; Systemic; Chemotherapy; Targeted therapy; Androgen deprivation therapy;
Keywords: درمان هدفمند; Metastatic renal cell carcinoma; Third line therapy; Targeted therapy;
Keywords: درمان هدفمند; Kidney; Tumor heterogeneity; Renal cell carcinoma; Clonal evolution; Targeted therapy; Precision immuno-oncology;
Keywords: درمان هدفمند; Personalized medicine; Phase I; Clinical trials; Targeted therapy; Genomic profiling;
Keywords: درمان هدفمند; Cancer; Hetero-isotherapy; Homeopathy; Immunotherapy; Tyrosine kinase inhibitor; Supportive care; Targeted therapy;
Keywords: درمان هدفمند; Renal cell carcinoma; Immunotherapy; Checkpoint inhibitors; Kidney cancer; Targeted therapy;
Keywords: درمان هدفمند; Cancer; Targeted therapy; Drug resistance;
Keywords: درمان هدفمند; Targeted therapy; Solid Tumors; Tyrosine kinase inhibitors; Monoclonal antibodies;
Keywords: درمان هدفمند; BCR-ABL-like; IKZF1 gene alteration; JAK inhibitors; Targeted therapy; Tyrosine kinase inhibitors;
Keywords: درمان هدفمند; AT-Rich interaction domain 1A; Bacillus Calmette-Guérin; DNA damage repair; Genomics; Immunotherapy; Nonmuscle invasive bladder cancer; Targeted therapy;
Keywords: درمان هدفمند; Drug dosing; Drug schedules; Oncology economics; Overall survival; Targeted therapy;
Keywords: درمان هدفمند; Cervical cancer; chemotherapy; metastatic; second-line; targeted therapy;
Keywords: درمان هدفمند; Urothelial cancer; Angiogenesis; HER2; Targeted therapy;
Keywords: درمان هدفمند; Molecular profiling; Epidemiology; Helicobacter pylori; Targeted therapy; Locally advanced disease;
Keywords: درمان هدفمند; Anti-EGFR; Efficacy; Monoclonal antibody; Safety; Targeted therapy;
Keywords: درمان هدفمند; Rhabdomyosarcoma; molecular pathology; PAX-FOXO1 fusion; epigenetics; targeted therapy; paediatric sarcoma;
Keywords: درمان هدفمند; Renal cell carcinoma; Metastasis; Targeted therapy; Tyrosine kinase inhibitor; Survival; Prognosis;
Keywords: درمان هدفمند; ostra biaÅaczka szpikowa; terapia celowana; standardy diagnostyki; badania kliniczne; nowe leki; Acute myleoid leukemia; Targeted therapy; Diagnostic standards; Clinical trials; New drugs;
Keywords: درمان هدفمند; Mucosal melanoma; Prognosis; Immune checkpoint blockade; Targeted therapy; KIT; Staging; Survival;
Keywords: درمان هدفمند; Matched therapy; Next-generation sequencing; NSCLC; Targeted therapy; Under genotyping;
Keywords: درمان هدفمند; ASH; American Society of Hematology; ATAP; amphipathic tail-anchoring peptide; BAD; BCL-2-associated death promoter protein; BAK; BCL-2 homologous antagonist killer; BAX; BCL-2-associated X protein; BCL-2; B-cell lymphoma 2; BCL-w (BCL2L2); BCL-2-like pro
Keywords: درمان هدفمند; mRCC; PPI; Targeted therapy; TKI; VEGF;
Keywords: درمان هدفمند; Diabetes; Kidney cancer; Prognosis; Sunitinib; Targeted therapy;
Keywords: درمان هدفمند; ALK; EGFR; Molecular markers; Screening; Targeted therapy;
Keywords: درمان هدفمند; Non-clear cell renal cell carcinoma; Classification; Prognosis; Surgical treatment; Targeted therapy;
Keywords: درمان هدفمند; Advanced thyroid cancer; adverse events; molecular targets; targeted therapy; tyrosine kinase inhibitors;
Keywords: درمان هدفمند; Melanoma; Metastatic; Network meta-analysis; Targeted therapy; Immune checkpoint inhibitor;
Keywords: درمان هدفمند; Vulvar cancer; Molecular alterations; Molecular targets; Targeted therapy;
Keywords: درمان هدفمند; Breast cancer; Brain metastases; Radiotherapy; Targeted therapy;
Keywords: درمان هدفمند; Breast cancer; Metastatic; Chemotherapy; Endocrine therapy; Targeted therapy; Overtreatment;
Keywords: درمان هدفمند; Vitiligo; Cellular stress; Autoimmunity; Chemokines; Targeted therapy; Melanogenesis;
Keywords: درمان هدفمند; Molecular pathology; soft tissue sarcoma; targeted therapy;
Keywords: درمان هدفمند; Melanoma; Stereotactic radiosurgery; Brain metastasis; Anti-PD-1 antibody; Immunotherapy; Targeted therapy; BRAF inhibitors;
Keywords: درمان هدفمند; Access; Innovative medicines; Metastatic melanoma; Treatment; Immunooncology; Targeted therapy; Health expenditure per capita; Human development index;
Keywords: درمان هدفمند; Targeted therapy; Cancer stem cells; Targeted therapy resistance; Combinational therapy; Anti-CSC therapy;
Keywords: درمان هدفمند; Pancreatic cancer; Molecular imaging; Targeted therapy; Image-guided cancer therapy; Theranostic nanoparticles;
Keywords: درمان هدفمند; Genomic biomarker; Kidney cancer; Targeted therapy; Everolimus; Sunitinib; Tumor suppressor gene; PBRM1; SETD2; BAP1; KDM5C;